Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope
- PMID: 21873707
- DOI: 10.1093/eurheartj/ehr344
Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope
Comment on
-
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.Eur Heart J. 2011 Oct;32(19):2387-94. doi: 10.1093/eurheartj/ehr342. Epub 2011 Aug 28. Eur Heart J. 2011. PMID: 21873708 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
